WallStreetZenWallStreetZen

NASDAQ: BPMC
Blueprint Medicines Corp Stock Ownership - Who owns Blueprint Medicines?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Blueprint Medicines Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christina RossiCHIEF OPERATING OFFICER2025-07-031,172$128.25
$150.31kSell
Percy H. CarterCHIEF SCIENTIFIC OFFICER2025-07-031,051$128.25
$134.79kSell
Lynn SeelyDirector2025-06-183,902$128.12
$499.92kBuy
Alexis BorisyDirector2025-06-183,902$128.12
$499.92kBuy
John TsaiDirector2025-06-183,902$128.12
$499.92kBuy
Mark Alan GoldbergDirector2025-06-183,902$128.12
$499.92kBuy
Habib J. DableDirector2025-06-183,902$128.12
$499.92kBuy
Lonnel CoatsDirector2025-06-183,902$12.81k
$49.99MBuy
Jeffrey W. AlbersDirector2025-06-183,902$128.12
$499.92kBuy
Daniella BeckmanDirector2025-06-183,902$128.12
$499.92kBuy

1 of 11

BPMC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BPMC insiders and whales buy or sell their stock.

BPMC Shareholders

What type of owners hold Blueprint Medicines Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.39%6,710,708$867.69MInstitution
Vanguard Group Inc10.28%6,640,523$858.62MInstitution
Kevin P. Starr8.44%5,453,753$705.17MInsider
Price T Rowe Associates Inc8.39%5,415,837$700.27MInstitution
Fmr LLC6.29%4,062,040$525.22MInsider
Avoro Capital Advisors LLC5.96%3,850,000$497.81MInstitution
Mark J. Levin5.52%3,564,997$460.95MInsider
Wellington Management Group LLP4.76%3,073,306$397.38MInstitution
State Street Corp4.16%2,684,117$347.06MInstitution
Jpmorgan Chase Co3.88%2,506,514$324.09MInstitution

1 of 3

BPMC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BPMC82.60%17.40%Net SellingNet Buying
TECH97.67%2.33%Net BuyingNet Buying
ROIV45.06%54.94%Net SellingNet Selling
VRNA10.60%52.47%Net SellingNet Selling
CORT29.74%70.26%Net BuyingNet Selling
View Top Biotech Stocks

Blueprint Medicines Stock Ownership FAQ

Who owns Blueprint Medicines?

Blueprint Medicines (NASDAQ: BPMC) is owned by 106.09% institutional shareholders, 22.36% Blueprint Medicines insiders, and 0.00% retail investors. Kevin P. Starr is the largest individual Blueprint Medicines shareholder, owning 5.45M shares representing 8.44% of the company. Kevin P. Starr's Blueprint Medicines shares are currently valued at $705.50M.

If you're new to stock investing, here's how to buy Blueprint Medicines stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.